Fair Accountability and Innovative Research Drug Pricing Act of 2019

Summary

Fair Accountability and Innovative Research Drug Pricing Act of 2019 This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 9 May 2019

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

   Source: IntroReferral

2. 9 May 2019

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 9 May 2019 · Download file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 9 May 2019

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 9 May 2019

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in Senate

  summary · EN · 9 May 2019

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Sen. Baldwin, Tammy [D-WI] · D · Sponsor
• Sen. Braun, Mike [R-IN] · R · Sponsor
• Sen. Murkowski, Lisa [R-AK] · R · Sponsor
• Sen. Smith, Tina [D-MN] · D · Sponsor
• Sen. King, Angus S., Jr. [I-ME] · I · Cosponsor
• Sen. Hoeven, John [R-ND] · R · Cosponsor
• Sen. Cramer, Kevin [R-ND] · R · Cosponsor
• Sen. Brown, Sherrod [D-OH] · D · Cosponsor
• · sshr00 · Standing

Related records

• related to → Fair Accountability and Innovative Research Drug Pricing Act of 2021
• related to → More Efficient Tools to Realize Information for Consumers Act
• related to ← Lower Health Care Costs Act
• related to ← Fair Accountability and Innovative Research Drug Pricing Act of 2017